Structure of CARDS toxin, a unique ADP-ribosylating and vacuolating cytotoxin from Mycoplasma pneumoniae

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2015-04-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.1420308112PMID 25848012PMCID PMC4413325
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ADP-Ribosylation of NLRP3 by Mycoplasma pneumoniae CARDS Toxin Regulates Inflammasome Activity

  2014influential reference
• Functional mapping of community‐acquired respiratory distress syndrome (CARDS) toxin of Mycoplasma pneumoniae defines regions with ADP‐ribosyltransferase, vacuolating and receptor‐binding activities

  2014influential reference
• Annexin A2 Mediates Mycoplasma pneumoniae Community-Acquired Respiratory Distress Syndrome Toxin Binding to Eukaryotic Cells

  2014influential reference
• Mycoplasma pneumoniae CARDS Toxin Is Internalized via Clathrin-Mediated Endocytosis

  2013cited by this paper
• The inflammasome in lung diseases.

  2012cited by this paper
• Mycoplasma pneumoniae CARDS toxin induces pulmonary eosinophilic and lymphocytic inflammation.

  2012cited by this paper
• Cellular Vacuoles Induced by Mycoplasma pneumoniae CARDS Toxin Originate from Rab9-Associated Compartments

  2011cited by this paper
• Persistence of community-acquired respiratory distress syndrome toxin-producing Mycoplasma pneumoniae in refractory asthma.

  2011cited by this paper
• Crystallographic Complexes of Surfactant Protein A and Carbohydrates Reveal Ligand-induced Conformational Change*

  2010influential reference
• Mycoplasma pneumoniae Community Acquired Respiratory Distress Syndrome toxin expression reveals growth phase and infection-dependent regulation

  2010influential reference
• Crystallization of community-acquired respiratory distress syndrome toxin from Mycoplasma pneumoniae.

  2010influential reference
• Analysis of Pulmonary Inflammation and Function in the Mouse and Baboon after Exposure to Mycoplasma pneumoniae CARDS Toxin

  2009cited by this paper
• Mycoplasma antigens as a possible trigger for the induction of antimitochondrial antibodies in primary biliary cirrhosis

  2009influential reference
• Needle in the haystack: structure-based toxin discovery.

  2008cited by this paper
• Structure and mode of action of a mosquitocidal holotoxin.

  2008cited by this paper
• A short history of SHELX.

  2008cited by this paper
• Crystal Structure of Botulinum Neurotoxin Type A in Complex with the Cell Surface Co-Receptor GT1b—Insight into the Toxin–Neuron Interaction

  2008cited by this paper
• Membrane lipids: where they are and how they behave

  2008cited by this paper
• Mycoplasma pneumoniae and its role in asthma

  2007cited by this paper
• ADP-ribosylating and vacuolating cytotoxin of Mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens.

  2006influential reference
• Identification and Characterization of Human Surfactant Protein A Binding Protein of Mycoplasma pneumoniae

  2005cited by this paper
• Immunoregulatory functions of surfactant proteins

  2005cited by this paper
• Mechanisms of Assembly and Cellular Interactions for the Bacterial Genotoxin CDT

  2005cited by this paper
• Structural Basis for the Activation of Cholera Toxin by Human ARF6-GTP

  2005cited by this paper
• Mycoplasma pneumoniae and Its Role as a Human Pathogen

  2004cited by this paper
• Coot: model-building tools for molecular graphics.

  2004cited by this paper
• Assembly and function of a bacterial genotoxin

  2004cited by this paper
• Mycoplasma pneumoniae: a reduced-genome intracellular bacterial pathogen.

  2003cited by this paper
• Generation, representation and flow of phase information in structure determination: recent developments in and around SHARP 2.0.

  2003influential reference
• The ARTT motif and a unified structural understanding of substrate recognition in ADP-ribosylating bacterial toxins and eukaryotic ADP-ribosyltransferases.

  2002cited by this paper
• Emerging from Obscurity: Understanding Pulmonary and Extrapulmonary Syndromes, Pathogenesis, and Epidemiology of Human Mycoplasma pneumoniae Infections

  2001cited by this paper
• The role of lipids in pulmonary surfactant.

  1998cited by this paper
• [20] Processing of X-ray diffraction data collected in oscillation mode.

  1997cited by this paper
• Mycoplasmas: sophisticated, reemerging, and burdened by their notoriety.

  1997cited by this paper
• Processing of X-ray diffraction data collected in oscillation mode.

  1997cited by this paper
• Three conserved consensus sequences identify the NAD‐binding site of ADP‐ribosylating enzymes, expressed by eukaryotes, bacteria and T‐even bacteriophages

  1996cited by this paper
• Interplay between mycoplasma surface proteins, airway cells, and the protean manifestations of mycoplasma-mediated human infections.

  1996cited by this paper
• NMRPipe: A multidimensional spectral processing system based on UNIX pipes

  1995cited by this paper
• The three-dimensional crystal structure of cholera toxin.

  1995cited by this paper
• Dali: a network tool for protein structure comparison.

  1995cited by this paper
• The crystal structure of pertussis toxin.

  1994cited by this paper
• Galactose‐binding site in Escherichia coli heat‐labile enterotoxin (LT) and cholera toxin (CT)

  1994cited by this paper
• The CCP4 suite: programs for protein crystallography.

  1994cited by this paper
• Pulmonary surfactant: Surface properties and function of alveolar and airway surfactant

  1992cited by this paper
• Structure of ricin B‐chain at 2.5 Å resolution

  1991cited by this paper
• Interaction of virulent Mycoplasma pneumoniae with hamster tracheal organ cultures

  1976cited by this paper
• Different biological properties of the two constituent peptide chains of ricin, a toxic protein inhibiting protein synthesis.

  1973cited by this paper
• STUDIES ON THE ETIOLOGY OF PRIMARY ATYPICAL PNEUMONIA

  1945cited by this paper
• STUDIES ON THE ETIOLOGY OF PRIMARY ATYPICAL PNEUMONIA

  1944cited by this paper
• Electronic Reprint Biological Crystallography Maximum-likelihood Density Modification Using Pattern Recognition of Structural Motifs Pattern Recognition of Structural Motifs

  year unknowncited by this paper
• Electronic Reprint Biological Crystallography Phenix : a Comprehensive Python-based System for Macromolecular Structure Solution

  year unknowninfluential reference

• Immune dysregulation in Mycoplasma pneumoniae pneumonia: mechanistic controversies and clinical translation from inflammatory dysregulation and immune evasion to chronic injury

  2026cites this paper
• Bacterial Toxin Exploits Host Membrane Phospholipid as a Receptor for Binding, Entry, and Cytopathogenicity

  2026cites this paper
• Clinical Characteristics of Severe Mycoplasma Pneumoniae Pneumonia Complicated with Arterial Ischemic Stroke in Children: A Systematic Analysis of 32 Cases

  2025cites this paper
• Uncovering the potential virulence factors of emerging pathogens using AI/ML-based tools: a case study in Emergomyces africanus

  2025cites this paper
• Dual mode of delivery of Mycoplasma pneumoniae CARDS toxin determines the toxin trafficking pathway and cytotoxicity in host cells

  2025cites this paper
• Growing Threat of Macrolide-Resistant Mycoplasma pneumoniae Among Children: What We Know and What We Need

  2025cites this paper
• The Immune Modulatory Role of Surfactants in Mycoplasma pneumoniae Infection

  2025cites this paper
• Advances in adhesion-related pathogenesis in Mycoplasma pneumoniae infection

  2025cites this paper
• Functional characterization of a novel Colletotrichum higginsianum effector candidate structurally resembling bacterial ADP-ribosyltransferase toxin proteins

  2025cites this paper
• Laboratory diagnosis and treatment of Mycoplasma pneumoniae infection in children: a review

  2024cites this paper
• Thioredoxin 1 moonlights as a chaperone for an interbacterial ADP-ribosyltransferase toxin

  2024cites this paper
• Risk association model for atelectasis complication in Mycoplasma pneumoniae pneumonia patients following standardized treatment

  2024cites this paper
• Association of serum interleukin-17 level and Mycoplasma pneumoniae pneumonia in children: a systematic review and meta-analysis

  2024cites this paper
• Mycoplasma: Properties, Detection, and Decontamination Methods of Cell Cultures and Viral Strains (Review)

  2024cites this paper
• Exploring the pathogenicity of Mycoplasma pneumoniae: Focus on community-acquired respiratory distress syndrome toxins.

  2024cites this paper
• Structure-Based Virtual Screening, ADMET Properties Prediction and Molecular Dynamics Studies Reveal Potential Inhibitors of Mycoplasma pneumoniae HPrK/P

  2024cites this paper
• In silico prediction of molecular mechanisms of toxicity mediated by the leptospiral PF07598 gene family-encoded virulence-modifying proteins

  2023cites this paper
• Mycoplasma pneumoniae – modern data on the structure, molecular biology and epidemiology of the pathogen

  2023cites this paper
• Periostin Modulating Mycoplasma pneumoniae Pneumonia in Children Related to Th17 Cell Function

  2023cites this paper
• Global research trends of Mycoplasma pneumoniae pneumonia in children: a bibliometric analysis

  2023cites this paper
• Bakuchiol reduces the severity of Mycoplasma pneumoniae-induced pneumonia in mice by attenuating inflammatory responses

  2023cites this paper
• Engineered live bacteria suppress Pseudomonas aeruginosa infection in mouse lung and dissolve endotracheal-tube biofilms

  2023cites this paper
• Pathogenic Leptospira Evolved a Unique Gene Family Comprised of Ricin B-Like Lectin Domain-Containing Cytotoxins

  2022cites this paper
• Characterization of a virulence-modifying protein of Leptospira interrogans identified by shotgun phage display

  2022cites this paper
• Green synthesised CuNPs using Alhagi maurorum extract and its ability to amelioration of Mycoplasma pneumoniae infected pneumonia mice model

  2022cites this paper
• MycoWiki: Functional annotation of the minimal model organism Mycoplasma pneumoniae

  2022cites this paper
• Kukoamine A Improves Mycoplasma pneumoniae Pneumonia by Regulating miR-222-3p/Superoxide Dismutase 2

  2022cites this paper
• A Rare Case of Severe Hemolytic Anemia and Pulmonary Embolism Secondary to Mycoplasma pneumoniae Infection

  2022cites this paper
• Evaluation of the CARDS toxin and its fragment for the serodiagnosis of Mycoplasma pneumoniae infections

  2021cites this paper
• Mycoplasma pneumoniae Infections: Pathogenesis and Vaccine Development

  2021influential citation
• Infection strategies of mycoplasmas: Unraveling the panoply of virulence factors

  2021influential citation
• Highly homogeneous microbial communities dominated by Mycoplasma pneumoniae instead of increased resistance to macrolide antibiotics is the characteristic of lower respiratory tract microbiome of children with refractory Mycoplasma pneumoniae pneumonia

  2021cites this paper
• Mycoplasma pneumoniae CARDS toxin exploits host cell endosomal acidic pH and vacuolar ATPase proton pump to execute its biological activities

  2021cites this paper
• NAD+-targeting by bacteria: an emerging weapon in pathogenesis.

  2021cites this paper
• Comparison of the Ameliorative Effects of Qing Zhi Zhi Ke Formula and Azithromycin on Mycoplasma pneumoniae Pneumonia in Mice

  2021cites this paper
• SARS-CoV-2, Zika viruses and mycoplasma: Structure, pathogenesis and some treatment options in these emerging viral and bacterial infectious diseases

  2021cites this paper
• Community-Acquired Respiratory Distress Syndrome Toxin: Unique Exotoxin for M. pneumoniae

  2021cites this paper
• Pathogenic Analysis of the Bronchoalveolar Lavage Fluid Samples With Pediatric Refractory Mycoplasma pneumoniae Pneumonia

  2020influential citation
• The efficiency of the polymerase chain reaction methods for the detection of common pathogens in patients with chronic obstructive pulmonary disease

  2020cites this paper
• COVID-19 Coronavirus: Is Infection along with Mycoplasma or Other Bacteria Linked to Progression to a Lethal Outcome?

  2020cites this paper
• Characterization of an Immunoglobulin Binding Protein (IbpM) From Mycoplasma pneumoniae

  2020cites this paper
• Mycoplasma pneumoniae: Atypical Pathogen in Community Acquired Pneumonia

  2020cites this paper
• Current perspectives on atypical pneumonia in children

  2020cites this paper
• Allergic airway sensitization impairs antibacterial IgG antibody responses during bacterial respiratory tract infections

  2019cites this paper
• Profile of proinflammatory cytokines in children with Mycoplasma pneumoniae pneumonia

  2019cites this paper
• tRNA 2'-phosphotransferase

  2019cites this paper
• Disulfide bond of Mycoplasma pneumoniae community‐acquired respiratory distress syndrome toxin is essential to maintain the ADP‐ribosylating and vacuolating activities

  2019cites this paper
• Benefits and risks of therapeutic alternatives for macrolide resistant Mycoplasma pneumoniae pneumonia in children

  2019cites this paper
• Structure of tRNA splicing enzyme Tpt1 illuminates the mechanism of RNA 2′-PO4 recognition and ADP-ribosylation

  2019cites this paper
• High expression of miR-222-3p in children with Mycoplasma pneumoniae pneumonia

  2019cites this paper
• Влияние Mycoplasma pneumoniae и рекомбинантного CARDS-токсина на клетки альвеолярного эпителия человека: эффекты протеина а сурфактанта на патогенные свойства микроорганизма in vitro

  2019cites this paper
• Pathogenic Mycoplasma Infections in Chronic Illnesses: General Considerations in Selecting Conventional and Integrative Treatments

  2019cites this paper
• CReasPy-cloning: a method for simultaneous cloning and engineering of megabase-sized genomes in yeast using the CRISPR-Cas9 system

  2019cites this paper
• Identification of essential and virulence genes in Mycoplasma pneumoniae

  2019cites this paper
• High co-expression of TNF-α and CARDS toxin is a good predictor for refractory Mycoplasma pneumoniae pneumonia

  2019cites this paper
• Extra-pulmonary diseases related to Mycoplasma pneumoniae in children: recent insights into the pathogenesis

  2018cites this paper
• Clinical and histologic features of Mycoplasma pneumoniae–related erythema multiforme: A single‐center series of 33 cases compared with 100 cases induced by other causes

  2018cites this paper
• The Mycoplasma pneumoniae HapE alters the cytokine profile and growth of human bronchial epithelial cells

  2018cites this paper
• Mycoplasma pneumoniae: A Potentially Severe Infection

  2018cites this paper
• Mycoplasma pneumoniae Community-Acquired Respiratory Distress Syndrome Toxin Uses a Novel KELED Sequence for Retrograde Transport and Subsequent Cytotoxicity

  2018cites this paper
• Mycoplasma pneumoniae CARDS toxin elicits a functional IgE response in Balb/c mice

  2017cites this paper
• A novel Ffu fusion system for secretory expression of heterologous proteins in Escherichia coli

  2017cites this paper
• Mycoplasma pneumoniae from the Respiratory Tract and Beyond

  2017cites this paper
• Additional corticosteroids or alternative antibiotics for the treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia

  2017cites this paper
• NLRP3 Is a Critical Regulator of Inflammation and Innate Immune Cell Response during Mycoplasma pneumoniae Infection

  2017cites this paper
• Mycoplasma pneumoniae infection: Basics

  2017cites this paper
• Association between mycoplasma pneumoniae infection and asthma : a meta-analysis and systematic reviews

  2017cites this paper
• Pneumonia, Acute Respiratory Distress Syndrome, and Early Immune-Modulator Therapy

  2017cites this paper
• MIB–MIP is a mycoplasma system that captures and cleaves immunoglobulin G

  2016cites this paper
• Chronic Infection and Severe Asthma.

  2016cites this paper
• Potential Molecular Targets for Narrow-Spectrum Agents to Combat Mycoplasma pneumoniae Infection and Disease

  2016cites this paper
• A Compendium for Mycoplasma pneumoniae

  2016cites this paper
• Infection with and Carriage of Mycoplasma pneumoniae in Children

  2016cites this paper
• Comparative “-omics” in Mycoplasma pneumoniae Clinical Isolates Reveals Key Virulence Factors

  2015cites this paper